LH

Labcorp Holdings Inc.

Investor Moves

NameValueActionChangePriceCurrent Price
Steven CohenPoint72
$69.3M
AddQ1 2026
$69M
--
$268.63
Ken GriffinCitadel Advisors
$-47.5M
ExitQ1 2026
$47M
--
$268.63
Charles BrandesBrandes Investment Partners
$9.5M
AddQ1 2026
$9.5M
--
$268.63
John W. Rogers Jr.Ariel Investments
$4.1M
AddQ1 2026
$4.1M
--
$268.63
Jefferies GroupInvestor
$-1.8M
TrimQ1 2026
$1.8M
--
$268.63
Ray DalioBridgewater Associates
$-1.4M
TrimQ1 2026
$1.4M
--
$268.63

Congress Trades

NameValueActionAmount RangePriceCurrent Price
Tony WiedRepublican
$33k
BuyFeb 19, 2026
$15k-$50k
--
$268.63
April DelaneyDemocrat
$8.0k
BuyFeb 11, 2026
$1k-$15k
--
$268.63
April DelaneyDemocrat
$8.0k
BuyFeb 4, 2026
$1k-$15k
--
$268.63
April DelaneyDemocrat
$8.0k
BuyJan 28, 2026
$1k-$15k
--
$268.63
April DelaneyDemocrat
$8.0k
BuyNov 17, 2025
$1k-$15k
--
$268.63
April DelaneyDemocrat
$8.0k
BuyOct 31, 2025
$1k-$15k
--
$268.63

Insider Trades

NameValueActionPriceCurrent Price
Kyle Kathryn WEVP, Chief Legal Officer
$201k762 shares
SellJun 8, 2026
$263.89
$268.63

News

zacks.comWhy Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Termzacks.comJun 8zacks.comHere's Why Labcorp Holdings (LH) is a Strong Value Stockzacks.comJun 5seekingalpha.comLabcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 3zacks.comLH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?zacks.comJun 1gurufocus.comLabcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancergurufocus.comMay 29